Goldman Sachs Sees Allergan as Potential Takeover Target, Ups Price Target (AGN)
July 13th, 2010

Health care products maker Allergan, Inc. (AGN) on Tuesday saw its price target boosted by analysts at Goldman Sachs.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!




RSS


Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the